Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Blood

• Publication date

  2003-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2003-01-0198PMID 12869512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Generation of Cytotoxic Responses in Mice and Human Individuals Against Hematological Malignancies Using Survivin-RNA-Transfected Dendritic Cells1

  2003cited by this paper
• Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice

  2002cited by this paper
• Expression and immunogenicity of oncofetal antigen-immature laminin receptor in human renal cell carcinoma.

  2001cited by this paper
• The generation of LMP2a‐specific cytotoxic T lymphocytes for the treatment of patients with Epstein‐Barr virus‐positive Hodgkin disease

  2001cited by this paper
• Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

  2000cited by this paper
• A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use.

  2000cited by this paper
• Human Dendritic Cells Transfected with RNA Encoding Prostate-Specific Antigen Stimulate Prostate-Specific CTL Responses In Vitro1

  2000cited by this paper
• 37kDa oncofetal antigen is an autoimmunogenic homologue of the 37kDa laminin receptor precursor

  2000cited by this paper
• 37 kiloDalton oncofetal antigen protein and immature laminin receptor protein are identical, universal T-cell inducing immunogens on primary rodent and human cancers.

  1999cited by this paper
• Role of the 37 kDa laminin receptor precursor in the life cycle of prions.

  1999cited by this paper
• Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes.

  1999cited by this paper
• Tumors express both unique TSTA and crossprotective 44 kDa oncofetal antigen.

  1998cited by this paper
• Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA

  1998cited by this paper
• The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells

  1997cited by this paper
• A new immunobiological view of radiation-promoted lymphomagenesis.

  1997cited by this paper
• CD8 T cell clones inhibit antitumor T cell function by secreting IL-10.

  1995cited by this paper
• Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, long-term survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning.

  1995cited by this paper
• Differential recognition of murine tumor-associated oncofetal transplantation antigen and individually specific tumor transplantation antigens by syngeneic cloned BALB/c and RFM mouse T cells.

  1994cited by this paper
• Laminin receptors and laminin-binding proteins during tumor invasion and metastasis.

  1993cited by this paper
• Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.

  1989cited by this paper
• Radiation-induced lymphoblastic lymphomas/leukemias and sarcomas of mice express conserved, immunogenic 44-kilodalton oncofetal antigen.

  1988cited by this paper

• Targeted drug delivery to AML by OFA/iLRP aptamer guided DNA nanostructure

  2026influential citation
• The Significance of the Microenvironment in T/Nk-Cell Neoplasms

  2025cites this paper
• Overview on Immunopathology of Chronic Lymphocytic Leukemia and Tumor-Associated Antigens with Therapeutic Applications

  2024influential citation
• Channeling the Natural Properties of Sindbis Alphavirus for Targeted Tumor Therapy

  2023cites this paper
• The use of a new selective AB3 aptamer for the hematologic tumor cells’ detection

  2023cites this paper
• The Research Advances of Aptamers in Hematologic Malignancies

  2023cites this paper
• Immune escape and immunotherapy of acute myeloid leukemia.

  2020cites this paper
• Protein and Peptide Nanocluster Vaccines.

  2020cites this paper
• Patented therapeutic approaches targeting LRP/LR for cancer treatment

  2019influential citation
• Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells

  2019cites this paper
• Novel Approaches to Acute Myeloid Leukemia Immunotherapy

  2018cites this paper
• Cross-Linked Peptide Nanoclusters for Delivery of Oncofetal Antigen as a Cancer Vaccine.

  2018cites this paper
• Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients

  2018cites this paper
• Recent Advances in the Function of the 67 kDa Laminin Receptor and its Targeting for Personalized Therapy in Cancer.

  2017cites this paper
• 67 kDa laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach?

  2016cites this paper
• Monoclonal antibodies specific for oncofetal antigen – immature laminin receptor protein: Effects on tumor growth and spread in two murine models

  2015cites this paper
• An update on current and prospective immunotherapies for chronic lymphocytic leukemia.

  2015cites this paper
• Oncofetal antigen/immature laminin receptor protein in pregnancy and cancer

  2014cites this paper
• mRNA-based therapeutics — developing a new class of drugs

  2014cites this paper
• Immunogenicity of in vitro maintained and matured populations: potential barriers to engraftment of human pluripotent stem cell derivatives.

  2013cites this paper
• Immunogenicity of Stem Cells

  2013cites this paper
• Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation

  2012cites this paper
• Phage display—A powerful technique for immunotherapy

  2012cites this paper
• Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemia.

  2012cites this paper
• Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria

  2012cites this paper
• Immunomodulatory drugs and active immunotherapy for chronic lymphocytic leukemia.

  2012cites this paper
• Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia

  2012cites this paper
• hTERT, CD23 und CD229 als Tumorantigene bei der B-CLL

  2012influential citation
• Sindbis viral vectors target hematopoietic malignant cells

  2012cites this paper
• Immune dysfunction in chronic lymphocytic leukemia: the role for immunotherapy.

  2012cites this paper
• Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations

  2011cites this paper
• High expression of the immature laminin receptor protein correlates with mutated IGVH status and predicts a favorable prognosis in chronic lymphocytic leukemia.

  2011cites this paper
• Avaliação da transfecção de células dendríticas com RNA tumoral como estratégia para indução de imunidade específica em pacientes com leucemia linfóide crônica.

  2010cites this paper
• Phase 1 Trial of Allogeneic Gene-Modified Tumor Cell Vaccine RCC-26/CD80/IL-2 in Patients with Metastatic Renal Cell Carcinoma

  2010cites this paper
• Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation.

  2010cites this paper
• Immunological and molecular studies for the development of vaccine therapy for chronic lymphocytic leukemia

  2010influential citation
• Towards New Therapeutic Targets: Identification of Novel Tumor Markers in Chronic Lymphocytic Leukemia

  2010cites this paper
• Whole tumor antigen vaccines.

  2010cites this paper
• Production, safety and antitumor efficacy of recombinant Oncofetal Antigen/immature laminin receptor protein.

  2009cites this paper
• Generation of a Dendritic Cell‐based Vaccine in Chronic Lymphocytic Leukaemia Using CliniMACS Platform for Large‐scale Production

  2009cites this paper
• Sperm-Derived SPANX-B Is a Clinically Relevant Tumor Antigen That Is Expressed in Human Tumors and Readily Recognized by Human CD4+ and CD8+ T Cells

  2009cites this paper
• In-vivo detectable antibodies directed against the oncofetal antigen/immature laminin receptor can recognize and control myeloma cells—clinical implications

  2008cites this paper
• Humoral Immune Responses against the Immature Laminin Receptor Protein Show Prognostic Significance in Patients with Chronic Lymphocytic Leukemia12

  2008influential citation
• RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses.

  2008cites this paper
• Vaccine therapy and chronic lymphocytic leukaemia.

  2008cites this paper
• Humoral Immune Responses against the Immature Laminin Receptor Protein Show Prognostic Significance in Patients with Chronic Lymphocytic Leukemia 1 , 2

  2008influential citation
• Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia

  2008cites this paper
• Leukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia Cells

  2008cites this paper
• Leukemia‐associated antigens as target structures for a specific immunotherapy in chronic myeloid leukemia

  2008cites this paper
• Activation of autologous leukemia‐specific T cells in acute myeloid leukemia: monocyte‐derived dendritic cells cocultured with leukemic blasts compared with leukemia‐derived dendritic cells

  2008cites this paper
• Identification of Tumour Associated Antigens as Potential Targets for the Immunotherapy of B-cell Chronic Lymphocytic Leukaemia (B-CLL)

  2008cites this paper
• Current status of peptide vaccines for cancer immunotherapy in malignant myeloid diseases

  2008cites this paper
• Gene therapy, vaccines, and immune modulation

  2008cites this paper
• New Therapies in Chronic Lymphocytic Leukemia

  2008cites this paper
• CLL: a paradigm of tumor-associated immune dysfunction

  2008cites this paper
• Translational applications of antibody phage display

  2008cites this paper
• Immunity Protective and Therapeutic Antitumor T Cell-Mediated + CCR 6 Elicit Potent CD 8 Antigen-Expressing Vaccines that Target Tumor-Associated Embryonic

  2007influential citation
• [F-18]-Fluoro-2-deoxy-d-glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model

  2007cites this paper
• Tumor-Associated Embryonic Antigen-Expressing Vaccines that Target CCR6 Elicit Potent CD8+ T Cell-Mediated Protective and Therapeutic Antitumor Immunity1

  2007influential citation
• Immunotherapy of myeloid leukaemia

  2007cites this paper
• Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia‐associated antigen associated with autoantibody response in a subset of patients

  2007cites this paper
• Nonintegrin laminin receptor precursor protein is expressed on olfactory stem and progenitor cells

  2007cites this paper
• Effector and Regulatory T Cell Clones Activate BALB/c Mouse OFA/iLRP-Specific Laminin Receptor Protein Epitopes That Identification of Oncofetal Antigen/Immature

  2006cites this paper
• “FEDERICO II” UNIVERSITY OF NAPLES

  2006cites this paper
• Targets and strategies for T-cell based vaccines in patients with B-cell chronic lymphocytic leukemia

  2006influential citation
• Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8+ T-cell responses.

  2006cites this paper
• Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.

  2006cites this paper
• Vaccine- and immune-based therapy in chronic lymphocytic leukemia.

  2006cites this paper
• Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia.

  2006cites this paper
• Identification of Oncofetal Antigen/Immature Laminin Receptor Protein Epitopes That Activate BALB/c Mouse OFA/iLRP-Specific Effector and Regulatory T Cell Clones1

  2006cites this paper
• Treatment approaches and nursing considerations for non-Hodgkin's lymphoma.

  2006cites this paper
• Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8 (cid:1) T-cell responses

  2006cites this paper
• Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches.

  2006cites this paper
• Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2

  2006cites this paper
• Identification of HLA-A*0201-Presented T Cell Epitopes Derived from the Oncofetal Antigen-Immature Laminin Receptor Protein in Patients with Hematological Malignancies

  2006cites this paper
• Patients with Hematological Malignancies Antigen-Immature Laminin Receptor Protein Cell Epitopes Derived from the Oncofetal Identification of HLA-A * 0201-Presented T

  2006cites this paper
• Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigens.

  2006cites this paper
• Antigen-specific cellular immunotherapy of leukemia

  2005cites this paper
• Developing phage display tools for use in transfusion medicine

  2005cites this paper
• Adoptive immunotherapy to treat leukemic relapse following allogeneic hematopoietic stem cell transplantation

  2005cites this paper
• mRNA expression of tumor associated antigens in patients with chronic lymphocytic leukemia

  2005cites this paper
• RNA NÁDOROVÉ VAKCÍNY NA BÁZI DENDRITICK ̄CH BUNùK RNA CANCER VACCINES BASED ON DENDRITIC CELLS

  2005cites this paper
• The natural history of a novel, systemic, disseminated model of syngeneic mouse B-cell lymphoma

  2005cites this paper
• Vaccine strategies to treat lymphoproliferative disorders.

  2005cites this paper
• Cancer immunotherapy with mRNA‐transfected dendritic cells

  2004influential citation
• Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses.

  2004cites this paper
• Molecules and mechanisms of the graft-versus-leukaemia effect

  2004cites this paper
• Novel approaches to immunotherapy for B-cell malignancies

  2004cites this paper
• Role of gammadelta T lymphocytes in tumor defense.

  2004cites this paper
• Expression of RHAMM / CD 168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia

  year unknowncites this paper